{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:02:04Z","timestamp":1790665324860,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jhepr.2021.100281","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T09:45:43Z","timestamp":1616319943000},"page":"100281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A human liver chimeric mouse model for non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"3","author":[{"given":"Beatrice","family":"Bissig-Choisat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Alves-Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Zorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Ochsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Barzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Legras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Borowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Thao N.","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Lagor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Sumazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Dimiter","family":"Bissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100281_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease \u2013 meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100281_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhepr.2021.100281_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhepr.2021.100281_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","article-title":"Obesity and cancer: the oil that feeds the flame","volume":"23","author":"Font-Burgada","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2021.100281_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100281_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/oby.21855","article-title":"Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model","volume":"25","author":"Han","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhepr.2021.100281_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41467-017-00049-x","article-title":"A\u00a0novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism","volume":"8","author":"Barzi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2021.100281_bib8","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1038\/ncomms8339","article-title":"Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model","volume":"6","author":"Bissig-Choisat","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2021.100281_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100281_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","article-title":"Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet","volume":"15","author":"Hatori","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2021.100281_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41597-019-0193-4","article-title":"The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways","volume":"6","author":"Ochsner","year":"2019","journal-title":"Sci Data"},{"key":"10.1016\/j.jhepr.2021.100281_bib12","doi-asserted-by":"crossref","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","article-title":"PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements","volume":"45","author":"Mi","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2021.100281_bib13","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","article-title":"The reactome pathway knowledgebase","volume":"44","author":"Fabregat","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2021.100281_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41597-020-00628-6","article-title":"Consensus transcriptional regulatory networks of coronavirus-infected human cells","volume":"7","author":"Ochsner","year":"2020","journal-title":"Sci Data"},{"key":"10.1016\/j.jhepr.2021.100281_bib15","doi-asserted-by":"crossref","first-page":"20507","DOI":"10.1073\/pnas.0710528105","article-title":"Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model","volume":"104","author":"Bissig","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhepr.2021.100281_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhepr.2021.100281_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)81073-9","article-title":"Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4","volume":"85","author":"Olson","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2021.100281_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/hum.1994.5.4-449","article-title":"Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism","volume":"5","author":"Valera","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jhepr.2021.100281_bib19","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2021.100281_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.119.258517","article-title":"Characterization of vitamin A metabolome in human livers with and without nonalcoholic fatty liver disease","volume":"370","author":"Zhong","year":"2019","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jhepr.2021.100281_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100281_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022775","article-title":"Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model","volume":"6","author":"Gorden","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jhepr.2021.100281_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057165","article-title":"Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis","volume":"8","author":"Wattacheril","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jhepr.2021.100281_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100281_bib25","doi-asserted-by":"crossref","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100281_bib26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100281_bib27","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.freeradbiomed.2004.06.033","article-title":"Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease","volume":"37","author":"Videla","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhepr.2021.100281_bib28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2021.100281_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2021.100281_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jhepr.2021.100281_bib31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2021.100281_bib32","first-page":"332","article-title":"Role of SREBPs in liver diseases: a mini-review","volume":"6","author":"Moslehi","year":"2018","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2021.100281_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cmet.2009.05.009","article-title":"Identification of cholesterol-regulating genes by targeted RNAi screening","volume":"10","author":"Bartz","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2021.100281_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2337\/db20-0619","article-title":"ETV5 regulates hepatic fatty acid metabolism through PPAR signaling pathway","volume":"70","author":"Mao","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2021.100281_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","article-title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations","volume":"51","author":"Futema","year":"2014","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jhepr.2021.100281_bib36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhepr.2021.100281_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/oby.2007.518","article-title":"Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients","volume":"15","author":"Elizondo","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhepr.2021.100281_bib38","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/oby.2009.379","article-title":"Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients","volume":"18","author":"Araya","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhepr.2021.100281_bib39","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbadis.2009.08.015","article-title":"Enhancement in liver SREBP-1c\/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion","volume":"1792","author":"Pettinelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2021.100281_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target","volume":"10","author":"Liu","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2021.100281_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2014.08.045","article-title":"Challenges to liver transplantation and strategies to improve outcomes","volume":"148","author":"Dutkowski","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100281_bib42","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.sla.0000251747.80025.b7","article-title":"Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study","volume":"245","author":"McCormack","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2021.100281_bib43","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2021.100281_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12986-016-0122-x","article-title":"Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice","volume":"13","author":"Geisler","year":"2016","journal-title":"Nutr Metab"},{"key":"10.1016\/j.jhepr.2021.100281_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/joe.1.06333","article-title":"Differential effect of inbred mouse strain (C57BL\/6, DBA\/2, 129T2) on insulin secretory function in response to a high fat diet","volume":"187","author":"Andrikopoulos","year":"2005","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.jhepr.2021.100281_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.clnu.2018.08.008","article-title":"Lean non-alcoholic fatty liver disease","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhepr.2021.100281_bib47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100281_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of Gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:27:31Z","timestamp":1762900051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2589555921000574"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100281","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A human liver chimeric mouse model for non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100281"}}